Trachoma clinical trials at UCSF
1 in progress, 0 open to eligible people
Sorry, not currently recruiting here
The investigators propose a cluster-randomized clinical trial to determine whether an intensive, targeted azithromycin distribution strategy is effective for elimination of trachoma at the kebele level compared to the World Health Organization (WHO) recommendation of annual azithromycin distribution.
San Francisco, California and other locations
Our lead scientists for Trachoma research studies include Thomas Lietman.